Key result
Pim1 inhibitors, particularly CX-6258, reduced Enterovirus A71 reproduction by more than 1,000 times, representing a potential therapeutic agent for EV-A71 treatment.
Why the study?
Enterovirus A71 causes hand-foot-and-mouth disease and fatal neurological diseases, but effective treatments are lacking.
Pim1 inhibitors, particularly CX-6258, significantly reduce EV-A71 reproduction, presenting a potential therapeutic target for hand-foot-and-mouth disease.
Pim1 inhibition merits further preclinical testing for EV-A71; leaves open clinical translation and efficacy.
Enterovirus A71 (EV-A71) infection causes hand-foot-and-mouth disease (HFMD) and fatal neurological diseases, and there are no effective treatments. Host factors play key roles in establishing viral infection and determining the disease progression and outcome of antiviral therapies. In this study, we found that the expression of Pim1 was significantly upregulated in EV-A71 infection. Ectopic expression or silencing of Pim1 promoted or inhibited EV-A71 replication through two distinct mechanisms. Pim1 enhanced viral IRES activity by increasing viral 2A protease-mediated eIF4G cleavage and blocked AUF1, a suppressor of IRES, translocation from the nucleus to cytosol. More importantly, we discovered that Pim1 inhibitors (SGI-1776, AZD-1208, and CX-6258) reduced EV-A71 reproduction. Particularly, CX-6258 remarkably reduced EV-A71 reproduction more than 1,000 times, providing a potential therapeutic agent for EV-A71 treatment.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2019) studied Enterovirus A71 (EV-A71) infection. Pim1 inhibitors (SGI-1776, AZD-1208, and CX-6258) was evaluated on EV-A71 reproduction. Pim1 inhibitors, particularly CX-6258, reduced Enterovirus A71 reproduction by more than 1,000 times, representing a potential therapeutic agent for EV-A71 treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: